ReviewCardiovascular diabetology. Endocrinology reports2026
Unveiling the heterogeneity of T2DM: a narrative review of clustering algorithms in stratifying comorbidity and complication risk.
Review in Cardiovascular diabetology. Endocrinology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Diabetes is a growing global health concern, affecting 537 million adults worldwide, significantly contributing to mortality and disability. Cluster analysis, a branch of Unsupervised machine learning (ML), has been increasingly used to identify distinct subgroups of patients with diabetes, enabling better disease stratification and personalized treatment strategies. Despite the growing burden of diabetes, clinical management often relies on generalized treatment approaches that may not account for patient heterogeneity. There is a need to better understand the underlying subtypes of diabetes to enable more personalized care. This narrative review evaluates the application of clustering in stratifying diabetes patients across diverse populations based on clinical, biomarker, and molecular characteristics and more. A literature search was conducted using PubMed, and Google Scholar following the Scale for the Assessment of Narrative Review Articles (SANRA) guidelines. A total of 22 articles were finalized to be included in the analysis where different clustering approaches on diabetes patients have been used. This review further classifies the studies into diabetes subgroups focusing specifically on type 2 diabetes patients where Severe Autoimmune Diabetes (SAID), Severe Insulin Deficient Diabetes (SIDD), Mild Obesity-Related Diabetes (MOD), and Mild Age-Related Diabetes (MARD) clusters were most commonly found, and biomarker-based classification such as inflammatory and molecular including only type 2 diabetes patients, where additional two clusters: Severe Insulin Resistant Diabetes with Relative Insulin Insufficiency (SIRD-RII), and Mild Age-Related Diabetes with Relative Insulin Insufficiency (MARD-RII), were found. This review underscores the potential of clustering in diabetes research and identifies gaps in standardization across studies. Future research should focus on refining clustering approaches, mainly introducing soft clustering to identify if patients fall in more than 1 cluster.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.